The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on P78333
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Biological Process: GO:0001523 retinoid metabolic process GO:0006024 glycosaminoglycan biosynthetic process GO:0006027 glycosaminoglycan catabolic process GO:0009966 regulation of signal transduction
BC039730 - Homo sapiens glypican 5, mRNA (cDNA clone MGC:47702 IMAGE:5744533), complete cds. AK312815 - Homo sapiens cDNA, FLJ93248, Homo sapiens glypican 5 (GPC5), mRNA. BC030584 - Homo sapiens cDNA clone IMAGE:4826683, containing frame-shift errors. AF001462 - Homo sapiens glypican-5 (GPC5) mRNA, complete cds. U66033 - Human glypican-5 (GPC5) mRNA, complete cds. CU691756 - Synthetic construct Homo sapiens gateway clone IMAGE:100020891 5' read GPC5 mRNA. JF432362 - Synthetic construct Homo sapiens clone IMAGE:100073555 glypican 5 (GPC5) gene, encodes complete protein. KJ891168 - Synthetic construct Homo sapiens clone ccsbBroadEn_00562 GPC5 gene, encodes complete protein. JD487385 - Sequence 468409 from Patent EP1572962. JD358700 - Sequence 339724 from Patent EP1572962. JD544477 - Sequence 525501 from Patent EP1572962. JD439411 - Sequence 420435 from Patent EP1572962. JD294896 - Sequence 275920 from Patent EP1572962. JD230630 - Sequence 211654 from Patent EP1572962. JD536878 - Sequence 517902 from Patent EP1572962. JD464297 - Sequence 445321 from Patent EP1572962. JD376870 - Sequence 357894 from Patent EP1572962. JD214516 - Sequence 195540 from Patent EP1572962.
Biochemical and Signaling Pathways
Reactome (by CSHL, EBI, and GO)
Protein P78333 (Reactome details) participates in the following event(s):
R-HSA-5362427 Hh-Np binds GPC5 R-HSA-1878002 XYLTs transfer Xyl to core protein R-HSA-1889955 B3GATs transfer GlcA to tetrasaccharide linker R-HSA-1889978 B3GALT6 transfers Gal to the tetrasaccharide linker R-HSA-2022919 EXT1:EXT2 transfers GlcNAc to the terminal GlcA residue R-HSA-1889981 B4GALT7 transfers Gal group to xylosyl-unit of the tetrasaccharide linker R-HSA-2076419 HS6STs sulfate GlcN at C6 in heparan sulfate/heparin R-HSA-2022887 NDST1-4 N-deacetylates GlcNAc residues in heparan R-HSA-2076392 EXT1:EXT2 transfers GlcA to heparan R-HSA-2076371 GLCE epimerises more GlcA to IdoA as sulfate content rises R-HSA-2076508 HS2ST1 sulfates IdoA at C2 in heparan sulfate R-HSA-2024100 GLCE epimerises GlcA to IdoA R-HSA-2022856 EXT1:EXT2 transfers GlcNAc to heparan R-HSA-2022851 EXT1:EXT2 transfer GlcNAc to the heparan chain R-HSA-2022860 NDST1-4 can sulfate a glucosamine residue in heparan to form heparan sulfate (HS) R-HSA-2076383 HS3ST1 sulfates GlcN at C3 in heparan sulfate R-HSA-2076611 HS3STs sulfate GlcN at C3 in heparan sulfate R-HSA-1678694 Heparanase 2 (HPSE2) cleaves heparan sulfate from its proteoglycan (plasma membrane) R-HSA-1667005 Heparanase (HPSE) cleaves heparan sulfate from its proteoglycan (lysosome) R-HSA-5362553 NOTUM releases Hh-Np:GPC5 from the plasma membrane R-HSA-2423785 CR:atREs binds apoE and HSPG R-HSA-2429643 NREH hydrolyses atREs (HSPG:apoE) to atROL and FAs R-HSA-2404131 LRPs transport extracellular CR:atREs:HSPG:apoE to cytosol R-HSA-5362798 Release of Hh-Np from the secreting cell R-HSA-1971475 A tetrasaccharide linker sequence is required for GAG synthesis R-HSA-3560801 Defective B3GAT3 causes JDSSDHD R-HSA-2022928 HS-GAG biosynthesis R-HSA-3656253 Defective EXT1 causes exostoses 1, TRPS2 and CHDS R-HSA-3656237 Defective EXT2 causes exostoses 2 R-HSA-4420332 Defective B3GALT6 causes EDSP2 and SEMDJL1 R-HSA-3560783 Defective B4GALT7 causes EDS, progeroid type R-HSA-2024096 HS-GAG degradation R-HSA-5358346 Hedgehog ligand biogenesis R-HSA-1638091 Heparan sulfate/heparin (HS-GAG) metabolism R-HSA-1793185 Chondroitin sulfate/dermatan sulfate metabolism R-HSA-3560782 Diseases associated with glycosaminoglycan metabolism R-HSA-975634 Retinoid metabolism and transport R-HSA-5358351 Signaling by Hedgehog R-HSA-1630316 Glycosaminoglycan metabolism R-HSA-3781865 Diseases of glycosylation R-HSA-2187338 Visual phototransduction R-HSA-6806667 Metabolism of fat-soluble vitamins R-HSA-162582 Signal Transduction R-HSA-71387 Metabolism of carbohydrates R-HSA-1643685 Disease R-HSA-418594 G alpha (i) signalling events R-HSA-196854 Metabolism of vitamins and cofactors R-HSA-1430728 Metabolism R-HSA-388396 GPCR downstream signalling R-HSA-372790 Signaling by GPCR